HIGHLIGHTS
- who: Zhengping Pu from the (UNIVERSITY) have published the Article: Berberine improves negative symptoms and cognitive function in patients with chronic schizophrenia via anti-inflammatory effect: a randomized clinical trial, in the Journal: (JOURNAL) of 25/08/2022
- what: Background Based on the neuroinflammation hypothesis in and known anti-inflammatory effects of the aim of this study is to investigate the efficacy of in treating and deficits in adult patients with Methods Enrolled participants were randomized to receive or placebo for 3 months. To verify this hypothesis and explore for a new therapeutic targets, in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.